A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer
Anticancer Research · 2024
DOI: 10.21873/anticanres.16953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Gerasimos Ardavanis-Loukeris und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1 Medical Oncology Clinic, Saint-Savvas Anticancer Hospital, Athens, Greece. Hauptthemen laut MEDLINE: Everolimus, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1 Medical Oncology Clinic, Saint-Savvas Anticancer Hospital, Athens, Greece.
- 1 Medical Oncology Clinic, Saint-Savvas Anticancer Hospital, Athens, Greece; stefkokka@med.uoa.gr.
- Oncology Unit, 2 Department of Medicine, National and Kapodistrian University of Athens, Medical School, Hippocratio General Hospital of Athens, Athens, Greece.
Zitieren
APA
Ardavanis-Loukeris, G., Kokkali, S., Perdikari, K., Karatrasoglou, E., Talagani, S., Tzovaras, A., & Ardavanis, A. (2024). A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16953
Vancouver
Ardavanis-Loukeris G, Kokkali S, Perdikari K, Karatrasoglou E, Talagani S, Tzovaras A, et al. A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.16953
BibTeX
@article{ArdavanisLoukeris2024,
author = {Ardavanis-Loukeris, Gerasimos and Kokkali, Stefania and Perdikari, Konstantina and Karatrasoglou, Eleni and Talagani, Sofia and Tzovaras, Alexandros and Ardavanis, Alexandros},
title = {A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16953}
}
EUVIMED